Bio-Techne Corp. (TECH), Tuesday announced the expanded launch and first shipment of its next-generation Leo System, expecting to deliver unmatched precision and efficiency in protein analysis.
Powered by Simple Western Technology, the system introduces dual-channel fluorescence detection alongside chemiluminescence, expanding data throughput and efficiency, and generating greater insights from precious samples.
Will Geist, President of the Protein Sciences Segment at Bio-Techne, said, "With advanced detection technologies and built-in compliance features, Leo enables researchers to achieve faster, more reliable results, accelerate critical discoveries, and streamline development timelines."
TECH closed at $60.29, down 2.25 percent on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Health News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.